tirzepatide libido study UC Irvine researchers project cardiac benefits from weight-loss medication tirzepatide Tirzepatide on ingestive behavior in
Description
Unlike some medications with known acnegenic propertiessuch as corticosteroids, lithium, or certain anticonvulsantstirzepatide does not have obvious pharmacologic properties that would directly promote acne formation
People with specific historiessuch as medullary thyroid carcinoma, MEN 2, certain pancreatic or gallbladder diseasesmay not be appropriate candidates
It contains no preservative and matches physiological ionic strength useful for isotonic compatibility studies but not the general reconstitution default
Studies observe how biological systems stabilize and respond under controlled conditions
For this study, researchers will observe approximately 150 participants who are 12 to 17 years of age who either have obesity (a body mass index, or BMI, equal to or above the 95th percentile) or participants between 12 and 17 who are overweight (a BMI between the 85th and 94th percentile) with at least one weight-related comorbidity
The Company at its sole discretion may utilize third-party services to perform identify verification
